CIM INVESTMENT MANAGEMENT INC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
CIM INVESTMENT MANAGEMENT INC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$222,000
-21.6%
1,435
-33.4%
0.07%
-25.0%
Q2 2021$283,000
+16.5%
2,155
-11.9%
0.09%
+11.4%
Q4 2020$243,000
+4.3%
2,4460.0%0.08%
-10.2%
Q3 2020$233,000
-13.7%
2,446
+1.5%
0.09%
-19.3%
Q2 2020$270,000
+29.2%
2,410
+20.5%
0.11%
+31.3%
Q4 2019$209,000
-41.1%
2,000
-43.9%
0.08%
-37.6%
Q3 2019$355,000
-12.8%
3,5650.0%0.13%
-10.7%
Q2 2019$407,000
-10.9%
3,565
-1.9%
0.15%
-15.3%
Q1 2019$457,000
+58.1%
3,635
+70.9%
0.18%
+40.8%
Q4 2018$289,000
-18.4%
2,127
-18.2%
0.12%
-3.1%
Q3 2017$354,000
-44.0%
2,599
-50.0%
0.13%
-42.4%
Q2 2017$632,000
+11.3%
5,203
-3.0%
0.22%
+14.9%
Q1 2017$568,000
+4.2%
5,3660.0%0.20%
-1.5%
Q4 2016$545,000
-0.5%
5,3660.0%0.20%
-5.3%
Q3 2016$548,000
-10.9%
5,366
+4.1%
0.21%
-18.0%
Q2 2016$615,000
+85.8%
5,156
+68.9%
0.26%
+67.8%
Q4 2015$331,000
+26.8%
3,0530.0%0.15%
+20.6%
Q3 2015$261,000
-3.7%
3,053
+13.6%
0.13%
+5.9%
Q2 2015$271,000
-34.7%
2,688
-50.0%
0.12%
-33.9%
Q1 2015$415,000
+45.1%
5,3790.0%0.18%
+37.4%
Q4 2014$286,000
+31.2%
5,379
+16.1%
0.13%
+18.0%
Q3 2014$218,0004,6350.11%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders